tiprankstipranks
Trending News
More News >
CTS Corporation (CTS)
:CTS
US Market
Advertisement

CTS (CTS) Earnings Dates, Call Summary & Reports

Compare
124 Followers

Earnings Data

Report Date
Oct 22, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.61
Last Year’s EPS
0.63
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 24, 2025|
% Change Since: -7.31%|
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong growth in diversified end markets, particularly in aerospace and defense, and improved financial metrics. However, challenges in the transportation sector, particularly in China, and softness in certain medical diagnostics segments highlight areas of concern.
Company Guidance -
Q3 2025
During the second quarter of 2025, CTS Corporation provided guidance indicating a solid financial performance and strategic progress amidst challenging market conditions. The company reported sales of $135 million, marking a 4% increase year-over-year, with diversified end market sales rising by 13%, significantly driven by the SyQwest acquisition which contributed $4.5 million. Adjusted EBITDA improved by 250 basis points sequentially and 130 basis points from the previous year. Diversified markets accounted for 55% of overall revenue, with aerospace and defense sales soaring by 34%, including a 6% organic growth. The medical market saw an 8% sales increase with therapeutic products up 60%. However, transportation sales fell by 6% due to China market dynamics. The company maintained its full-year guidance, projecting sales between $520 million and $550 million, and adjusted diluted EPS ranging from $2.20 to $2.35. CTS emphasized its strategic focus on diversification, operational efficiency, and strategic acquisitions to support long-term growth, despite external pressures from tariffs and geopolitical uncertainties.
Strong Diversified End Market Sales
Diversified end market sales, including medical, aerospace, and defense, were up 13%, driven by organic growth and the SyQwest acquisition. These markets comprised 55% of overall revenue.
Aerospace and Defense Growth
Sales in aerospace and defense increased 34% from the previous year, with a 6% rise excluding the SyQwest acquisition. SyQwest contributed $4.5 million in revenue.
Improved Financial Performance
Adjusted EBITDA improved by 250 basis points sequentially and 130 basis points year-over-year. Adjusted diluted earnings rose to $0.57 per share, a 30% increase from the first quarter and 7% from the prior year.
Strong Cash Flow and Liquidity
Operating cash flow was $28 million in the second quarter, with a cash balance of $99 million and long-term debt at $88 million, providing good liquidity for strategic acquisitions.
Industrial Market Recovery
Industrial market sales were up 5% sequentially and 6% year-over-year, with bookings increasing 22% from the same period last year.

CTS (CTS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CTS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 22, 2025
2025 (Q3)
0.61 / -
0.63
Jul 24, 2025
2025 (Q2)
0.55 / 0.57
0.545.56% (+0.03)
Apr 30, 2025
2025 (Q1)
0.49 / 0.44
0.47-6.38% (-0.03)
Feb 04, 2025
2024 (Q4)
0.54 / 0.53
0.4712.77% (+0.06)
Oct 29, 2024
2024 (Q3)
0.54 / 0.63
0.5416.67% (+0.09)
Jul 30, 2024
2024 (Q2)
0.53 / 0.54
0.59-8.47% (-0.05)
May 01, 2024
2024 (Q1)
0.41 / 0.47
0.61-22.95% (-0.14)
Feb 06, 2024
2023 (Q4)
0.46 / 0.47
0.56-16.07% (-0.09)
Oct 26, 2023
2023 (Q3)
0.56 / 0.54
0.62-12.90% (-0.08)
Jul 25, 2023
2023 (Q2)
0.55 / 0.59
0.62-4.84% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CTS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 24, 2025
$40.44$42.00+3.86%
Apr 30, 2025
$39.85$38.04-4.54%
Feb 04, 2025
$49.18$46.98-4.47%
Oct 29, 2024
$48.41$49.60+2.46%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does CTS Corporation (CTS) report earnings?
CTS Corporation (CTS) is schdueled to report earning on Oct 22, 2025, Before Open (Confirmed).
    What is CTS Corporation (CTS) earnings time?
    CTS Corporation (CTS) earnings time is at Oct 22, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CTS EPS forecast?
          CTS EPS forecast for the fiscal quarter 2025 (Q3) is 0.61.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis